Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: A cohort study

Journal of the International AIDS Society

Volumn 17, Issue , 2014, Pages

  Phillips, Tamsin ^a   Thebus, Elizabeth ^a   Bekker, Linda Gail ^a   Mcintyre, James ^a   Abrams, Elaine J ^a   Myer, Landon ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Antiretroviral therapy; HIV AIDS; Postpartum; Pregnancy; Prevention of mother to child transmission (PMTCT); Retention; South africa

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; TENOFOVIR; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREGNANCY; PRENATAL PERIOD; PUERPERIUM; RETROSPECTIVE STUDY; SOUTH AFRICA; HIV INFECTIONS; PATIENT ATTITUDE; PREGNANCY COMPLICATIONS, INFECTIOUS;

ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; PATIENT ACCEPTANCE OF HEALTH CARE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 84908544639     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.17.1.19242     Document Type: Article

References (49)

1. Joint United Nations Programme on HIV/AIDS. 2013 Progress Report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2013.
2. Sturt A, Dokubo E, Sint T. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 2010;3. Art. No.: CD008440.
3. Kumwenda J, Matchere F, Mataya R, Chen S, Mipando L, Li Q, et al. Coverage of highly active antiretroviral therapy among postpartum women in Malawi. Int J STD AIDS. 2011;22:368 - 72.
4. National Department of Health. The South African antiretroviral treatment guidelines. Pretoria, South Africa: National Department of Health; 2013.
5. Ferguson L, Grant AD, Watson-Jones D, Kahawita T, Ong'ech JO, Ross DA. Linking women who test HIV-positive in pregnancy-related services to longterm HIV care and treatment services: a systematic review. Trop Med Int Health. 2012;17:564 - 80.
6. Myer L, Zulliger R, Black S, Pienaar D, Bekker L-G. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa. AIDS Care. 2012;24:986 - 92.
7. Killam WP, Tambatamba BC, Chintu N, Rouse D, Stringer E, Bweupe M, et al. Antiretroviral therapy in antenatal care to increase treatment initiation in HIVinfected pregnant women: a stepped-wedge evaluation. AIDS. 2010;24:85 - 91.
8. Stinson K, Jennings K, Myer L. Integration of antiretroviral therapy services into antenatal care increases treatment initiation during pregnancy: a cohort study. PLoS One. 2013;8:e63328.
9. Myer L, Zulliger R, Bekker L, Abrams E. Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIVpositive mothers: a cohort study. BMC Pregnancy Childbirth. 2012;12:94.
10. Chibwesha C, Giganti M, Putta N, Chintu N, Mulindwa J, Benjamin J, et al. Optimal time on HAART for prevention of mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2013;58:224 - 8.
11. Van Schalkwyk M, Andersson MI, Zeier MD, La Grange M, Taljaard JJ, Theron GB. The impact of revised PMTCT guidelines: a view from a public sector ARV clinic in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2013;63:234 - 8.
12. Denoeud-Ndam L, Fourcade C, Ogouyemi-Hounto A, Azon-Kouanou A, D'Almeida M, Azonde? kon A, et al. Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin. PLoS One. 2013;8: e59446.
13. Fitzgerald FC, Bekker L-G, Kaplan R, Myer L, Lawn SD,Wood R. Mother-tochild transmission of HIV in a community-based antiretroviral clinic in South Africa. S Afr Med J. 2010;100:827 - 31.
14. World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a publich health approach. Geneva: World Health Organization; 2013.
15. Nachega JB, Uthman O, Anderson J, Peltzer K,Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and metaanalysis. AIDS. 2012;26:2039-52.
16. Wang B, Losina E, Stark R, Munro A, Walensky RP, Wilke M, et al. Loss to follow-up in a community clinic in South Africa - roles of gender, pregnancy and CD4 count. South African Med J. 2011;101:253 - 7.
17. MacPherson P, Lalloo DG, Choko AT, Mann GH, Squire SB, Mwale D, et al. Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi. Trop Med Int Health. 2012;17:507-17.
18. Boyles TH, Wilkinson LS, Leisegang R, Maartens G. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One. 2011;6:e19201.
19. Kaplan R, Orrell C, Zwane E, Bekker L-G, Wood R. Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS. 2008;22:1679 - 81.
20. Ngarina M, Popenoe R, Kilewo C, Biberfeld G, Ekstrom AM. Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania. BMC Publ Health. 2013;13:450.
21. Watson-Jones D, Balira R, Ross DA, Weiss HA, Mabey D. Missed opportunities: poor linkage into ongoing care for HIV-positive pregnant women in Mwanza, Tanzania. PLoS One. 2012;7:e40091.
22. Stinson K, Myer L. HIV-infected women's experiences of pregnancy and motherhood in Cape Town, South Africa. Vulnerable Child Youth Stud. 2012; 7:36-46.
23. Muchedzi A, Chandisarewa W, Keatinge J, Stranix-chibanda L, Woelk G, Mbizvo E, et al. Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban Zimbabwe. J Int AIDS Soc. 2010;13:38.
24. Bekker L, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service. Programme performance over 3 consecutive years in Guguletu, South Africa. South African Med J. 2006;96: 315 - 20.
25. National Department of Health; South African National AIDS Council. Clinical guidelines: PMTCT (Prevention of Mother-to-Child Transmission). Pretoria, South Africa: National Department of Health; 2010.
26. Clouse K, Pettifor A, Shearer K, Maskew M, Bassett J, Larson B, et al. Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Trop Med Int Health. 2013; 18:451-60.
27. Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B-') in Malawi. AIDS. 2014; 28:589-98.
28. Ayuo P, Musick B, Liu H, Braitstein P, Nyandiko W, Otieno-Nyunya B, et al. Frequency and factors associated with adherence to and completion of combination antiretroviral therapy for prevention of mother to child transmission in western Kenya. J Int AIDS Soc. 2013;16:17994.
29. Black V, Hoffman RM, Sugar CA, Menon P, Venter F, Currier JS, et al. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;49:276 - 81.
30. Nassali M, Nakanjako D, Kyabayinze D, Beyeza J, Okoth A, Mutyaba T. Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program. AIDS Care. 2009;21:1124-31.
31. Van Lettow M, Bedell R, Mayuni I, Mateyu G, Landes M, Chan AK, et al. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B-). J Int AIDS Soc. 2014;17:18994.
32. Stinson K, Myer L. Barriers to initiating antiretroviral therapy during pregnancy: a qualitative study of women attending services in Cape Town, South Africa. African J AIDS Res. 2012;11:65 - 73.
33. Otieno PA, Kohler PK, Bosire RK, Brown ER, Macharia SW, John-Stewart GC. Determinants of failure to access care in mothers referred to HIV treatment programs in Nairobi, Kenya. AIDS Care. 2010;22:729-36.
34. Boateng D, Kwapong GD, Agyei-Baffour P. Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional study. BMC Wom Health. 2013;13:2.
35. Futterman D, Shea J, Besser M, Stafford S, Desmond K, Comulada WS, et al. Mamekhaya: a pilot study combining a cognitive-behavioral intervention and mentor mothers with PMTCT services in South Africa. AIDS Care. 2010;22: 1093-100.
36. Rotheram-Borus M-J, Richter L, Van Rooyen H, van Heerden A, Tomlinson M, Stein A, et al. Project Masihambisane: a cluster randomised controlled trial with peer mentors to improve outcomes for pregnant mothers living with HIV. Trials. 2011;12:2.
37. th International AIDS Conference; 2014 Jul 20 -25; Melbourne, Australia.
38. Myer L, Harrison A. Why do women seek antenatal care late? Perspectives from rural South Africa. J Midwifery Wom Health. 2003;48:268-72.
39. Ebeigbe PN, Ndidi EP, Igberase GO, Oseremen IG. Reasons given by pregnant women for late initiation of antenatal care in the niger delta, Nigeria. Ghana Med J. 2010;44:47-51.
40. Lubega M, Musenze IA, Joshua G, Dhafa G, Badaza R, Bakwesegha CJ, et al. Sex inequality, high transport costs, and exposed clinic location: reasons for loss to follow-up of clients under prevention of mother-to-child HIV transmission in eastern Uganda -a qualitative study. Patient Prefer Adherence. 2013; 7:447-54.
41. Ekama SO, Herbertson EC, Addeh EJ, Gab-Okafor CV, Onwujekwe DI, Tayo F,et al. Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women. J Pregnancy. 2012;2012:851810.
42. Mepham S, Zondi Z, Mbuyazi A, Mkhwanazi N, Newell ML. Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care. 2011;23:741-7.
43. Vo BN, Cohen CR, Smith RM, Bukusi EA, Onono MA, Schwartz K, et al. Patient satisfaction with integrated HIV and antenatal care services in rural Kenya. AIDS Care. 2012;24:1442-7.
44. Suthar AB, Hoos D, Beqiri A, Lorenz-Dehne K, Duncombe C, McClure C. Integrating antiretroviral therapy into antenatal care and maternal and child health settings: a systematic review and meta-analysis. Bull World Health Organ. 2013;91:46-56.
45. Theuring S, Sewangi J, Nchimbi P, Harms G, Mbezi P. The challenge of referring HIV-positive pregnant women with treatment indication from PMTCT to ART services: a retrospective follow-up study in Mbeya, Tanzania. AIDS Care. 2014;26(7):850-6.
46. Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health. 2010;15:825-32.
47. Kranzer K, Lewis JJ, Ford N, Zeinecker J, Orrell C, Lawn SD, et al. Treatment interruption in a primary care antiretroviral therapy programme in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr. 2010;55:17-23.
48. Geng EH, Glidden DV, Bwana MB, Musinguzi N, Emenyonu N, et al. Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS One. 2011;6:e21797.
49. Holmes CB, Bengtson A, Sikazwe I, Bolton-Moore C, Mulenga LB, Musonda P, et al. Using the side door: non-linear patterns within the HIV treatment cascade in Zambia. 21st Conference on Retroviruses and Opportunistic Infections (CROI); 2014 Mar 3 -6; Boston, USA.